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Clostridium difficile infection (CDI) after ileostomy reversal is rare, with few reports available in the available literature 
describing this condition. The diagnosis of CDI after ileostomy reversal is challenging because symptoms such as diarrhea 
observed in these patients can occur frequently after surgery. However, CDI can be fatal, so early diagnosis and prompt 
treatment are important. We discuss 2 patients with positive C. difficile toxin assay results on stool cultures performed af-
ter ileostomy reversal. Clinical progression differed between these patients: one patient who presented with severe CDI 
and shock was successfully treated following a prolonged intensive care unit stay for the management of vital signs and 
underwent hemodialysis, while another patient showed symptoms of mild colitis but we could not confirm whether diar-
rhea was associated with CDI or with the usual postoperative state. To our knowledge, these represent 2 of just a few cases 
reported in the literature describing CDI after ileostomy reversal.
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INTRODUCTION
Clostridium difficile infection (CDI) is a major cause of hospital-
acquired infection that continues to achieve increasing levels of 
incidence and severity among hospitalized patients. Symptoms 
can range from mild diarrhea to fulminant colitis that can result 
in severe sepsis, toxic megacolon, and multiorgan failure, and this 
condition is associated with high mortality [1]. 
Few reports to date in the available literature have described 
CDI after ileostomy reversal. Reportedly, the incidence of CDI 
was significantly higher in patients who underwent ileostomy re-
versal than in patients who underwent other colorectal proce-
dures, including anterior resection, right hemicolectomy, and ap-
pendectomy [2]. The pathogenesis of this condition is attributed 
to mucosal colonization of the unused colon by C. difficile, follow-
ing the creation of a diverting ileostomy. In animal models, this is 
associated with changes in the microenvironment secondary to 
mucosal and muscular atrophy that occur in the defunctioned 
colon [3].
We report on 2 patients with positive C. difficile toxin assay re-
sults following stool cultures performed after ileostomy reversal. 
The clinical progression differed between these patients, although 
the toxin assay in both cases showed positive results for C. difficile.
CASE REPORTS
Case 1
A 65-year-old male visited the emergency department with a 
1-day history of abdominal pain and severe diarrhea. His blood 
pressure was 65/50 mmHg and pulse rate was 121 beats/min. 
Non-contrast-enhanced abdominopelvic computed tomography 
(CT) revealed edematous, thickened walls of the entire colon with 
pericolic fat infiltration and fluid collection (Fig. 1). Laboratory 
tests revealed a significantly elevated white blood cell count 
(32,810/μL) and serum levels of C-reactive protein (488 mg/L), 
procalcitonin (>100 ng/mL), and creatine (3.82 mg/dL). Stool 
toxin assays confirmed CDI. The patient was admitted to the in-
tensive care unit (ICU) owing to unstable vital signs. Conservative 
management was initiated with the administration of intravenous 
(IV) antibiotics and oral vancomycin due to a diagnosis of CDI-
induced shock. 
The patient’s history revealed he had undergone laparoscopic 
ultra-low anterior resection and creation of a diverting ileostomy 
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for rectal cancer after receiving chemoradiation therapy 8 months 
prior to the current presentation. He also had a past medical his-
tory of hypertension and diabetes mellitus. He had undergone 
elective ileostomy reversal 10 days earlier, receiving a single dose 
of parenteral cefotetan on the day of surgery and completing a 
successful surgery without any intraoperative events. His postop-
erative course was uneventful and he was discharged on the 5th 
postoperative day with medication for wound pain. 
Initially, he received inotropic medication and underwent he-
modialysis to support his vital signs, recovering gradually with 
this treatment. Inotropic agents were tapered completely on the 
10th day after admission to the ICU. He could tolerate a soft diet 
on the 12th day, and hemodialysis was discontinued on the 23rd 
day following admission to the ICU. Owing to his prolonged ICU 
stay, he required rehabilitation for muscle weakness and was sub-
sequently discharged 37 days after admission. Vancomycin was 
used for 14 days.
Case 2
A 57-year-old male was admitted for ileostomy reversal. He had 
undergone laparoscopic low anterior resection and creation of a 
diverting ileostomy for rectal cancer 8 months prior to this pre-
sentation. He had no notable past medical history other than he 
had undergone elective ileostomy reversal. At the time, he had re-
ceived a single dose of parenteral cefotetan on the day of the oper-
ation and undergone successful surgery without any intraopera-
tive events.
Postsurgery, he complained of vomiting and radiography re-
vealed ileus until the fifth postoperative day. His laboratory tests 
revealed no abnormalities. Watery diarrhea were observed on the 
sixth postoperative day, and a stool toxin assay confirmed the 
presence of C. difficile. Conservative management was initiated 
with the administration of IV antibiotics and oral vancomycin. 
He could tolerate a soft diet on the ninth postoperative day and 
was discharged on the 11th postoperative day without any com-
plications. Vancomycin was used for 7 days.
These case reports were approved by the Institutional Review 
Board of Severance Hospital and the requirement for informed 
consent was waived (No. 4-2019-0558).
DISCUSSION
Few case reports in the available literature have described CDI af-
ter ileostomy reversal [4-6]. Abe et al. [4] reported a case of severe 
fulminant CDI-induced colitis occurring 3 days after ileostomy 
reversal in a patient who died following emergency total colec-
tomy. Fashandi et al. [6] also described fulminant CDI at 3 days 
after ileostomy reversal in a patient who died on the fifth postop-
erative day despite emergency total colectomy. In the cases re-
ported by these authors, the patients showed a rapid deterioration 
in their clinical course beyond the scope of the conventional 
management algorithm. The patient reported as case 1 in our re-
port showed a similar fulminant course with severe pancolitis and 
shock. Early CT or colonoscopy is essential for the prompt diag-
nosis and treatment of pseudomembranous colitis. 
The early and accurate diagnosis of CDI based on symptomatic 
evaluation is challenging in patients undergoing ileostomy rever-
sal. Early symptoms of CDI such as diarrhea might be misdiag-
nosed as normal and expected findings in patients undergoing il-
eostomy closure. Almerie et al. [5] described a finding of CDI af-
ter ileostomy reversal is similar in a patient who presented with 
diarrhea, which was suspected to be secondary to causes such as 
anastomotic leak, iatrogenic bowel injury, or infectious colitis 
(based on elevated serum levels of inflammatory markers accom-
panying the diarrhea). Sudden and severe diarrhea accompanied 
by abdominal pain and elevated serum levels of inflammatory 
markers (as observed in case 1) should lead to a high index of 
clinical suspicion for CDI and warrant prompt diagnostic testing. 
Hussain et al. [7] described ileostomy effluent stool cultures and 
protein exotoxin detection in patients who were colonized with C. 
difficile before reversal. In their cohort of 20 patients, no individ-
ual presented a positive stool culture or exotoxin test results pre-
operatively, although stool culture and exotoxin test results were 
positive postoperatively. This result may be attributed to the fact 
that C. difficile colonizes the unused colon. Shen et al. [8] de-
scribed patients with fatal CDI-associated pouchitis after ileos-
tomy reversal. These patients underwent total proctocolectomy 
with ileal pouch-anal anastomosis (IPAA) to treat ulcerative coli-
tis. A study involving 115 patients with ulcerative colitis who un-
derwent IPAA reported that fecal C. difficile toxin testing revealed 
positive results in 18% of study participants [9]. 
Separately, the patient described in case 2 showed symptoms of 
mild diarrhea, and we could not confirm whether this diarrhea 
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was associated with CDI or the usual postoperative state. How-
ever, a C. difficile toxin assay showed positive results, indicating C. 
difficile colonization. Previous studies have reported that the risk 
of subsequent CDI was 5.9-fold higher among patients colonized 
with toxigenic C. difficile upon hospital admission than in non-
colonized patients [10]. Hospitalization within 3 months [10], 
chemotherapy within the previous 8 weeks [11], antibiotics usage 
[12] and acid suppression with proton pump inhibitors (PPIs) 
[13] have been reported as risk factors for C. difficile coloniza-
taion. Rubio-Perez et al. [14] reported a significant association be-
tween pseudomembranous colitis and delayed ileostomy reversal 
(of greater than 6 months), with the reported defunctioning time 
ranging from 9 to 15 months in these patients. Our 2 patients un-
derwent an operation 10 months after the first surgery due to ad-
juvant chemotherapy. Although neither patient received PPIs, the 
patient described in case 1 had received chemotherapy 8 weeks 
earlier, and both chemotherapy and acid suppressants serve as 
risk factors for colonization and CDI. 
A retrospective cohort study performed by Fernandes et al. [15] 
compared outcomes in patients before and after a change in anti-
microbial policy. The authors altered the antibiotic prophylaxis 
policy used in patients undergoing ileostomy reversal from the 
administration of three doses of metronidazole plus cefuroxime 
to a single dose of metronidazole to attempt to promote a reduc-
tion in CDI rates. The results showed a 5.8% decrease in CDI 
rates, and the postoperative diarrhea rate decreased from 32% to 
12.5%.
We report 2 cases of patients who showed positive C. difficile 
toxin assay results on stool cultures performed after ileostomy re-
versal. Despite the low incidence, the clinical presentation of this 
condition is often indistinguishable from the usual postoperative 
state; therefore, diagnosis is challenging. Fulminant cases are 
known to occur; therefore, clinicians must consider this condition 
in the differential diagnosis, and prompt evaluation is warranted 
in patients undergoing ileostomy reversal who present with severe 
diarrhea and abdominal pain. Clinicians should be aware of the 
risk factors for CDI or colonization and reduce the use of unwar-
ranted antibiotics and PPIs and consider earlier ileostomy reversal 
where appropriate.
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